Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 20 for “"GnRH agonists"”.
-
Real world evidence for the use of androgen deprivation therapy in prostate cancer
… Prolonged use of Gonadotropin Releasing Hormone (GnRH) agonists may be associated with survival benefits, but also with potential side-effects in men with PCa. One of the more recently investigated side-effects of ADT is an increased risk of cardiovascular disease (CVD). Observational studies that …
-
Η έκφραση των ιντεγκρινών α4, β1 και β3 στο ενδομήτριο γυναικών αναπαραγωγικής ηλικίας που πάσχουν από ενδομητρίωση
… Furthermore, the affect of treatment with GnRH-agonists in integrins expression was analysed.Materials and methods: 40 women with endometriosis underwent endometrial biopsy in order to investigate the expression of integrins. All the women had normal cycles and the biopsy was performed on …
-
Clinical outcomes for men diagnosed with prostate cancer
… men on gonadotropin releasing hormone receptor agonists: I investigated how having a treatment for metabolic disease-related components (‘metabolic drugs’) at the time of androgen deprivation therapy initiation was associated with prostate cancer mortality and overall mortality. Cox proportional …
-
Gonadotropin-Releasing Hormone Agonist Treatments Normalize Aromatase and Reduce Cyclooxygenase-2 in Ovarian Endometrioma and Eutopic Endometrium with Endometrosis
PURPOSE: To investigate whether GnRH agonists could normalize aromatase cytochrome P450 and cyclooxygenase-2 metabolism by direct action in the eutopic endometrium of endometriosis and ovarian endometrioma. METHODS: Endometrial specimens and ovarian endometrioma tissues were obtained from …
-
The impact of GnRH-agonist triggers on autologous in vitro fertilization outcomes: A retrospective analysis
… maturation before ultrasound guided aspiration. GnRH-agonists have been utilized as an alternative to hCG for oocyte maturation prior to follicle aspiration. GnRH-agonist triggers are proven to lower ovarian hyperstimulation syndrome risk, a condition that can be life threatening. Lower pregnancy …
-
The Effect of Triptorelin on Ovulation Rate and Conception Rate in Gilts and the Endocrine Profile in Non-Pregnant and Early pregnant Gilts
… rates of fixed timed AI protocols involving GnRH agonists are similar to standard AI, the conception rate versus ovulation rate may show differences in the two protocols. When comparing the ovulation rate with conception rate, our experiment has shown that GnRH agonists, accompanied by a …
-
A Study of Spermatogenesis in the Dog, With Specific Reference to the Role of the Leydig Cell
… the spermatozoa found in this section. Therefore GnRH agonists were considered. A Nafarelin derivative administered by osmotic subcutaneous pumps was used in two dogs, however, due to problems with the pumps, the treatment was ineffective until changed to daily subcutaneous injections. The results …
-
Vyrų krūties vėžys, priežastys, diagnostika, gydymas /
… treatment of metastatic male breast cancer and GnRH agonists, aromatase inhibitors and fulvestrant remain possible treatment alternatives. Chemotherapy is given when the disease continues to progress or when breast cancer is hormone receptor – negative. Conclusions and recommendations: Male …
-
Μελέτη των ενδοθηλιακών παραγόντων (σελεκτίνη, ρεσιστίνη, οιστραδιόλη, προγεστερόνη) και των δεικτών του οξειδωτικού stress ανάλογα με τα φαρμακευτικά πρωτόκολλα σε γυναίκες που υποβάλλονται σε εξωσωματική γονιμοποίηση
… women undergoing COH during IVF, using both GnRH agonist and antagonist protocols. Thus, the aim of this study was to measure these levels as well as to compare the serum and follicular fluid levels of selectin, resistin and ROS between women undergoing COH protocol for IVF with GnRH agonist …
-
Ο ρόλος της διαδερμικής χορήγησης τεστοστερόνης στη διέγερση των ωοθηκών σε γυναίκες με πτωχή ωοθηκική απάντηση που υποβάλλονται σε εξωσωματική γονιμοποίηση
… and gonadotrophin releasing hormone (GnRH) agonists. In addition, a systematic review and meta-analysis was performed aiming to evaluate testosterone pre-treatment on the probability of pregnancy achievement in poor responders undergoing ovarian stimulation for in-vitro fertilization …
-
The role of vascular endothelial growth factor and other cytokines in the aetiology of heavy menstrual bleeding in women with uterine fibroids
… who received gonadotropin releasing hormone agonists (GnRH), higher expression of VEGF mRNA in women who had GnRH agonists than those who had no any hormones. In fibroid tissue, GnRHdownregulated the expression of VEGF protein and other cytokines compared with those not on any hormonal …
-
Ultrastructural analysis of human immature oocytes retrieved after two different protocols of controlled ovarian hyperstimulation
… the effects of two different COH protocols, a GnRH agonist (fCOH) stimulation and a GnRH antagonist (mCOH) stimulation, on the fine structure of fresh human immature GV-stage oocytes, to consider the ultrastructure of well-preserved organelles as indicator of GV quality preservation. Fresh GVs …
-
Pharmacological characterization of novel GnRH analogues
The Gonadotropin-Releasing Hormone (GnRH) (or LHRH: luteinizing hormone-releasing hormone) is a decapeptide, which is produced and released in pulses from the hypothalamus, controlling the release of the gonadotropin hormones LH (luteinizing hormone) and FSH (follicle-stimulating hormone) from the …
-
In vitro μελέτη της επίδρασης των GNRH ανάλογων επί των λειτουργιών των ανθρωπίνων ωχρινοποιημένων κοκκωδών κυττάρων
The hypothalamic gonadotropin releasing hormone (GnRH) regulates via pituitary high affinity receptors (GnRHR-I) the biosynthesis and secretion of gonadotropins. In addition to its central action it has been suggested that GnRH exerts peripheral actions since the presence of GnRHR-I has been …
-
Surgical Costs Associated with the Treatment of Uterine Fibroids
… contraceptives, gonadotropin-releasing hormone (GnRH) agonists, GnRH antagonists, among other less used agents. The mainstay of curative therapies are surgical procedures with hysterectomies being the true curative option. Therefore, the focus of this thesis was on the all cause long-term …
-
The interaction between the PI3K/Akt cascade and the androgen receptor in the development and progression of castrate resistant prostate cancer
… using gonadotropin-releasing hormone (GnRH) agonists. The latter induces castrate levels of testosterone by down-regulating pituitary GnRH receptors (and therefore gonadotropin hormone production) through constant stimulation. The action of androgen may be blocked at a peripheral level …
-
Bridging gaps in diagnostic, management, and global policy frameworks for endometriosis
… progestogens (SMD 0.65; 95% 0.44, 0.87), and GnRH agonists (SMD 0.59; 95% CI 0.41, 0.77) ranked among the most effective treatments based on change scores, while acupuncture (SMD 1.45; 95% CI 0.59, 2.31), ranked highest on pain end scores. However, marked heterogeneity in methodology and …
-
Quantitative assessment, stability, and cytotoxicity activity of GnRH-toxin conjugates
… treated by surgical castration, sex steroid antagonists, and GnRH agonists or antagonists. However, these treatments have side effects and disadvantages. In view of non-specific toxicity of most chemotherapeutic agents against many normal cells, the development of targeted chemotherapy is …
-
STANDARDIZATION OF MINIMALLY INVASIVE SURGICAL AND PERI-SURGICAL PROCEDURES IN POND SLIDERS (TRACHEMYS SCRIPTA)
… in female pond sliders. The use of long-acting GnRH-agonists has been poorly investigated in reptiles, and the few available studies show inconsistent results. Twenty sexually mature turtles were divided into three groups: one single-implant groups (6 animals), one double-implant group (6 …
-
Μελέτη παραμέτρων αιματικής ροής μητριαίων και ωοθηκικών αρτηριών ανάλογα με τα πρωτόκολλα διέγερσης σε γυναίκες που υποβάλλονται σε εξωσωματική γονιμοποίηση
… and from 112 participating 62 followed the GnRH-antagonist and 50 the agonist protocol. Ovarian stimulation was achieved with random use of recombinant or urinary FSH. IVF cycles were monitored with transvaginal ultrasound. Endometrial thickness and uterine and ovarian blood flow indices …